sur AI/ML Innovations Inc. (CVE:AIML)
NeuralCloud Solutions Signs Agreement with Lakeshore Cardiology for AI-Powered Holter Analysis
NeuralCloud Solutions Inc., a subsidiary of AI/ML Innovations Inc., has entered into a non-binding agreement with Lakeshore Cardiology to deploy its CardioYield™ platform. This platform, powered by MaxYield™ technology, aims to enhance Holter monitoring through AI-driven ECG analysis. The collaboration seeks to integrate AI tools into clinical workflows, improving data interpretation and clinical decision-making.
The agreement involves a phased rollout of CardioYield™, starting with internal validation and a limited paid trial at Lakeshore Cardiology. Upon successful validation and Health Canada clearance, CardioYield™ will be available across Lakeshore's operations.
Esmat Naikyar, President of NeuralCloud, expressed commitment to advancing AI-driven ECG analysis, while Lakeshore's Martina Magnotta highlighted the platform's potential to enhance patient care. This partnership reflects the adaptability of AI in cardiac monitoring.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AI/ML Innovations Inc.